Market Overview

UPDATE: Sterne Agee Upgrades athenahealth to Neutral; Overhang Removed

Share:
Related ATHN
Rumor: Hedge Fund To Present Tesla Short Thesis At Sohn
Jefferies: Highlighting Athenahealth's Big Deal (Maybe)

Sterne Agee raised its rating on athenahealth (NASDAQ: ATHN) from Underperform to Neutral and increased its price target from $48.50 to $72.

Sterne Agee noted, "Contrary to our fears toward a significant air pocket in revenues created by the loss of a material channel partnership with PSS World Medical (PSSI, $28.48, NR), we now believe this relationship will continue. In hindsight, our industry checks had caused our view towards the ATHNPSSI partnership to become black and white, whereby we thought the partnership would end upon the consummation of PSSI's marriage with McKesson (MCK, $95.30, NR). We now believe McKesson will allow the PSS sales force the option to sell athena's solutions or MCK's solutions"

athenahealth closed at $73.89 on Friday.

Latest Ratings for ATHN

DateFirmActionFromTo
Mar 2015RW BairdInitiates Coverage onOutperform
Feb 2015Compass PointUpgradesMarket PerformOutperform
Jan 2015Stifel NicolausMaintainsBuy

View More Analyst Ratings for ATHN
View the Latest Analyst Ratings

Posted-In: Sterne AgeeAnalyst Color Upgrades Pre-Market Outlook Analyst Ratings

 

Related Articles (ATHN)

Around the Web, We're Loving...